Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study - Leclair, V; Galindo-Feria, A; Dastmalchi, M (Rheumatology (Oxford), 2019)
et al.